Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00389-2/fulltext?dgcid=hubspot_email_conferencealerts_uwclh23&utm_campaign=conferencealerts&utm_medium=email&_hsmi=282627408&_hsenc=p2ANqtz--F-2_SAigNoI9jMF56UlRQUAUwBgenG_wxl-Ibvha0ATl8lRynNHWWobk4qdAuwiTu_niAntj0su7NL95U8oAc2W55dQ&utm_content=282627408&utm_source=hs_email